ASK REDCHAT ANYTHING ABOUT SANGAMO THERAPEUTICS INC.
Sangamo Therapeutics Inc. (OTCQB: SGMO)
Listen to this Section
$0.17
-0.0430
(
-20.00% )
6.9M
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Giroctocogene fitelparvovec (SB-525 / PF-07055480)DetailsBlood disorder, Rare diseases, Hemophilia, Rare genetic disease |
Phase 3 |
| TX-200DetailsKidney disease, Kidney transplantation |
Phase 1/2 |
| ST-920 (isaralgagene civaparvovec)DetailsFabry disease, Rare genetic disease |
Phase 1/2 |
| BIVV003 (SAR445136)DetailsSickle cell disease, Blood disorder |
Failed |
| ST-400DetailsBlood disorder, Beta thalessemia |
Failed |
| SB-913DetailsGenetic disorder, Rare diseases, Mucopolysaccharidoses, Rare genetic disease, Mucopolysaccharidosis type II |
Failed |
| ST-503DetailsIdiopathic small fiber neuropathy |
Phase 1/2 |
Market Data
|
| Open |
$0.17 |
| Previous Close |
$0.22 |
| Volume |
6.9M |
| Market Cap |
$71.26M |
| Day Range |
$0.14 - $0.22 |
| 52 Week Range |
$0.10 - $0.77 |
| Shares Outstanding |
414.29M |
| Change % |
-20.00% |
| Net Change |
▼ -0.0430 |
| Insider Ownership |
0.00% |
| Exchange |
OTCQB |
| Sector | Healthcare |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| IPO Year | |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-10,569,305.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2023-11-28 |
Sale |
-1329.00 |
Willoughby Scott B. |
| 2023-09-28 |
Sale |
-6000000.00 |
BIOGEN INC. |
| 2023-08-29 |
Sale |
-1925.00 |
McClung David Mark |
| 2023-08-29 |
Sale |
-1029.00 |
Fontenot Jason D. |
| 2023-08-29 |
Sale |
-10411.00 |
Macrae Sandy |
| 2023-08-29 |
Sale |
-1462.00 |
Dubois-Stringfellow Nathalie |
| 2023-08-29 |
Sale |
-1329.00 |
Willoughby Scott B. |
| 2023-08-29 |
Sale |
-1329.00 |
Duraibabu Prathyusha |
| 2023-08-15 |
Sale |
-864.00 |
Willoughby Scott B. |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| schedule |
Other |
1 |
Nov 12, 2025 |
| 10-q |
Quarterly Reports |
69 |
Nov 06, 2025 |
| 8-k |
8K-related |
14 |
Nov 06, 2025 |
| 8-k |
8K-related |
12 |
Oct 29, 2025 |
| 4 |
Insider transactions |
1 |
Oct 24, 2025 |
| 4 |
Insider transactions |
1 |
Oct 24, 2025 |
| 4 |
Insider transactions |
1 |
Oct 24, 2025 |
| 4 |
Insider transactions |
1 |
Oct 24, 2025 |
| 4 |
Insider transactions |
1 |
Oct 24, 2025 |
| 4 |
Insider transactions |
1 |
Oct 24, 2025 |